Financial Tearsheet






Financial Tearsheet

Cronos Group is an innovative global cannabinoid company with international production and distribution networks across five continents. The Company is committed to building disruptive intellectual property and establishing an iconic brand portfolio.

Stock Chart

Stock Quote

Copyright West LLC. Minimum 15 minutes delayed.

News Releases

30 Mar 20
Cronos Group Reports 2019 Fourth Quarter and Full-Year Results
Completed Audit Committee Review and Restated Certain 2019 Unaudited Interim Financial Statements Expanded Canadian distribution to new provinces and product categories across the adult-use market Established Cronos Fermentation, a critical step in advancing the production of cultured cannabinoids
30 Mar 20
Cronos Group Inc. to Report 2019 Fourth Quarter and Full-Year Financial Results on March 30, 2020
TORONTO , March 30, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) will report its 2019 Fourth Quarter and Full-Year Financial Results on Monday, March 30, 2020 after the close of trading on NASDAQ.
17 Mar 20
Cronos Group to Restate Certain 2019 Unaudited Interim Financial Statements
TORONTO , March 17, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) announced today that the Company determined, on the recommendation of the Audit Committee of the Company’s Board of Directors and after consultation with KPMG LLP , the

SEC Filings

Filing date Description

40FR12B

F-X

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Events

30 March 2020 at 5:30 PM EDT
Cronos Group Full Year and Fourth Quarter 2019 Earnings Conference Call
30 January 2020 at 3:15 PM MST
Cronos Group at the 23rd Annual CIBC Western Institutional Investor Conference
14 January 2020 at 9:00 AM EST
Cronos Group at the 2020 ICR Conference